SkyePharma falls as Abbott gets shot of asthma drug – This is London


Genetic Engineering News

SkyePharma falls as Abbott gets shot of asthma drug
This is London
Drugmaker SkyePharma today saw its shares plunge 5% after pharmaceuticals giant Abbott Laboratories ended the deal to sell its asthma drug Flutiform in
SkyePharma loses US partnerGrowthBusiness.co.uk
Abbott bows out of Flutiform pactFierceBiotech
Abbott Returns US Flutiform Rights to SkyePharma after Negative FDA FeedbackGenetic Engineering News
ShareCast –Reuters –Wall Street Journal
all 14 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *